British Journal of Haematology · 2009 · 21 citations · 12 references
Life SciencesOncologyPathobiologyApoptosisChemotherapySignal TransductionApoptosis ModulationChemotherapy In Hematologic MalignanciesImmune Cell SignalingImmune ResponseAnti-proliferative SignalingAntiproliferative AgentsAntiproliferative Drug ActionHodgkin Lymphoma TherapyHodgkin Lymphoma TreatmentInterferon Regulatory Factor ActivationLymphoma ChemotherapyLymphoma Pathogenesis
The effects of proliferative, apoptotic and anti-proliferative stimuli on interferon regulatory factor 4 (IRF4) expression by Reed-Sternberg (RS) cells were analysed using a panel of Hodgkin lymphoma (HL)-derived cell lines. IRF4 expressed by HL cells was consistently upregulated after CD40 engagement; IRF4 was downregulated by agonistic anti-CD95 antibodies in the FAS-sensitive HDLM-2 cells and after treatment with Adriamycin and Dacarbazine, two chemotherapic agents commonly used for HL treatment. These results demonstrated, for the first time, that IRF4 was up-modulated by CD40 engagement, and down-modulated by apoptotic and anti-proliferative signals, suggesting an involvement of IRF4 also in HL pathobiology.
12
Antonino Carbone, Annunziata Gloghini, Luigi Maria Larocca et al. · Blood · 2001 · 237 citations · Full text